Lack of beneficiary effect of levothyroxine therapy of pregnant women with subclinical hypothyroidism in terms of neurodevelopment of their offspring.

Sima Nazarpour Fahimeh Ramezani Tehrani Firoozeh Sajedi Maryam Rahmati Razieh Bidhendi Yarandi Fereidoun Azizi

Published in: Archives of gynecology and obstetrics (2023)

Our study does not support the beneficiary effect of LT4 therapy for SCH pregnant women in terms of the neurological development of their offspring in the first three years of life.

Keyphrases

pregnant women
high fat diet
type diabetes
stem cells
replacement therapy
adipose tissue
skeletal muscle
brain injury
smoking cessation